What distinguishes Pharma Design from other service providers is that we offer cost-saving, targeted and dedicated support with a team of very specialised consultants. Our prices are competitive thanks to our lean and flexible business model, much more competitive than your usual CRO or service provider!
We have assisted large and small companies achieve market launch in Europe, starting from early development, by means of iterative exchange with Regulatory Authorities and developing a trusted relationship with Assessors.
We routinely prepare and submit CTA applications, PIPs and orphan designation applications on behalf of sponsors in EU, UK and Switzerland. We also assist our US clients with MAA strategy, preparation and submission in Europe.
CTA Applications in Europe
Our Values
The value we bring to pharmaceutical companies falls into four main areas:
- Objective, impartial advice tailored to your needs
- Help cut your development costs
- Help reduce your time to market
- Keep your drug on the market